OHSU study sheds light on ubiquitin modification during bacterial infection

New research from Oregon Health & Science University could one day lead to therapies that prevent or treat diseases and infections tied to a protein that’s found in all human cells.

Pharmalittle: Key Senate panel has a plan for PBMs; Roivant eyes $7 billion sale of a stomach drug

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

July 14, 2023

FDA approves Takeda’s colorectal cancer drug Fruzaqla – Pharmaceutical Technology

The drug is already approved in China and is also currently under review for marketing authorisation by the European Medicines Agency (EMA). Image credit: Shutterstock/Tada

November 9, 2023

After decades in use, heart stents finally beat placebo. It took a bold researcher

PHILADELPHIA — A new study, and the bold doctor who led it, could result in big questions about how researchers study medical devices and surgical

November 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.